Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Categories & Tags

From January 2015 the news articles published on Glycosmedia will be placed in categories and will have associated tags. This will allow you to quickly find articles relating to a particular specialty or interest.

To see all articles associated with a category or tag just click on the category or tag name under the item in the news listing or select from the lists below.

Categories

    • Audits
    • Bariatric
    • Biochemistry
    • Cardiovascular
    • Devices
    • Diagnosis
    • Diet
    • Education
    • Epidemiology
    • Genetics
    • Gestational
    • Guidance
    • Guidelines
    • Hepatology
    • Hypertension
    • Immunology
    • Management
    • Media
    • Medication
    • Meetings
    • Monitoring
    • Nephrology
    • Neuropathy
    • Nephropathy
    • Obesity
    • Ophthalmology
    • Paediatrics
    • Pathology
    • Pharma
    • Pharmacology
    • Physiology
    • Podiatry
    • Prediabetes
    • Prevalence
    • Prevention
    • Psychological
    • Reports
    • Research
    • Screening
    • Sponsorship
    • Technology
    • Testing
    • Transplantation
    • Treatment
    • Wound Care

Tags

To see all articles associated with a tag just click on the tag name from the list below. Larger font sizes indicate that more articles have been tagged using that word or phrase.

  • ABASAGLAR ABCD acarbose ACCORD ACE ACEI ADA adiponectin adiposity adolescents AF aflibercept AGE aging AI albumin albuminuria alcohol alogliptin American Diabetes Association amputation anaemia angiopoietin-like 2 antibiotic antibody anticoagulation antidepressant antihyperglycemic antioxidants Apoptosis Apps ARB ARR arterial calcification artificial pancreas Asian aspirin atherosclerosis atorvastatin atrial fibrillation autism autoantibodies autoimmune autoimmunity autonomic autonomic function B Cell B12 bariatric baroreflex barriers behavioral beta cell beta cells biofilm biomarker biomarkers bionic pancreas biosimilar BJGP bladder cancer blood glucose blood pressure BMI bolus bone bone fragility BP breast cancer bypass graft C-peptide canagliflozin cancer carbohydrate cardiometabolic risk Cardiovascular Care Processes CD4+ T cells central obesity CGM changeover Charcot children cholesterol CKD classification clinical inertia closed-loop closed‐loop coaching Cochrane cognitive colorectal combination therapy communication comorbidities complications continuous glucose monitoring Continuous Subcutaneous Insulin Infusion contrast-induced costs COVID ‐19 COVID-19 Coxsackie–adenovirus creatinine CSII CVD CVD risk dapagliflozin DDP4i degludec deintensification dementia Denmark depression diabetic foot diabetic foot ulcer Diabetic Ketoacidosis diabetic macular edema diabetic macular oedema diabetic retinopathy diagnosis disease DKA DKD double diabetes DPP-4 inhibitors DPP-4i DPP4 DPP4 inhibitors DPP4-I DPP4i driving dual therapy Dulaglutide dysglycaemia dysmetabolic profile EASD economic burden economics eGFR elderly EMA EMPA-REG Empagliflozin endothelial dysfunction endothelial function England enteroviral epigenetics epigenomics ertugliflozin ESRD Europe exenatide exercise exocrine fasting fasting glucose fat fats fatty liver FBG FDA feet ferritin fibrinogen Flash flash glucose follow up foot foot care foot disease foot risk foot ulcer foot ulcers Forxiga FPG fracture fracture risk fractures FreeStyle Libre GABA GAD GAD-alum gallbladder Gastric Bypass gastric emptying Gastroparesis GDM gender ghrelin Gilbert syndrome GIP GIP–GLP1-Receptor Agonists glargine gliclazide glimepiride gliptins global GLP-1 GLP-1 RA GLP-1 Receptor Agonist GLP-1 receptor agonists GLP-1RA GLP‐1RA GLP1 GLP1 receptor agonist glucagon glucose glucose tests glucose variability glyburide glycaemic control glycaemic variability Glycated albumin glycemic Index glycemic load glycemic response glycemic variability GP growth factors guidelines gut gut microbiota haptoglobin HbA1c HDL heart failure heart rate Helicobacter pylori hospital HQIP HRQOL HSCIC Hyperbaric hypercholesterolaemia hyperglycemia hyperkalaemia hyperosmolar hyperosmolar state hypertension hypoglycemia hypomagnesemia hypotension ibuprofen ICU IDF IDFD illness beliefs immunotherapy incidence incretin individual agency inertia infection infections inflammation influenza inpatient insulin insulin pen insulin pump insulin pumps Insulin resistance insulin secretion insulin sensitivity intensification intensive intensive glucose control intensive glycaemic control intensive remote Intensive therapy interleukin-2 intervention interventions intravenous insulin IR Islet Autoimmunity Islet cell transplantation islet dysfunction islet transplantation Jardiance Ketoacidosis kidney disease lactation lactic acidosis lada LAGB LDL LDL cholesterol leg muscle strength leptin Leptin-Melanocortin lifestyle Linagliptin lipid lipids lipoprotein liraglutide liver liver fat lixisenatide low-carbohydrate lower limb amputation LRTI lymph node macrovascular macular edema male MDI mediterranean diet memory metabolic surgery metabolomics metals metformin mGFR MI microalbuminuria microalbuminuric microangiopathy microbiome microbiota microvascular minor amputation MODY Monitoring Blood Glucose monocytes monogenic mortality musculoskeletal Myocardial Infarction NAFLD NASH NDTA neonatal nephropathy Netherlands neuropathy Neutrophil/lymphocyte Ratio newborns NHS NICE nocturnal nomogram Novo Nordisk nurse nutrition obesity OGTT older patients omentum oral oral insulin orthopaedic osteopontin Osteoporosis over 74 overnight oxidative stress PAD paediatric Pancreas pancreatic cancer pancreatitis periodontal periodontitis perioperative peripheral neuropathy pharmacist pharmacological physical activity pioglitazone PIONEER placebo Plasma Prekallikrein polypharmacy postpartum preconception prediabetes prediction pregnancy prepregnancy Prescribing prevention primary care probiotics protein proteinuria pump pumps QoL Ramadan ranibizumab red blood cell kinetics remission renal retinopathy revascularized risk factors risk prediction risk-factor rosiglitazone Roux-en-Y RT‐CGM RYGB saxagliptin Saxenda Sclerostin Scotland screening seasonal secure messaging self-adjustment self-care self-management self-monitoring self-stigma self-testing semaglutide Sepsis Serum 25-hydroxyvitamin D sexual dissatisfaction SGLT 2 inhibitors SGLT-2i SGLT2 SGLT2 inhibition SGLT2 inhibitor SGLT2 inhibitors SGLT2-I SGLT2i SIGN sitagliptin sleep sleeve gastrectomy sliding scale smartmat smartphone-based SMBG social sotagliflozin South Asian South Asians sRAGE statin statins stem cells stress stroke Suicide sulfonylureas surgery surgical survival targets technology TeleCare telemedicine testing testosterone ticagrelor Toujeo transition treatment Tresiba trials triglyceride triglycerides Type 1 Diabetes Type 2 Diabetes TZD UAE UK ulcer uric acid urinary biomarkers USA UTI vaccine varuability vascular Victoza videos vildagliptin Vitamin D Wales warfarin weight gain weight loss weight management WHO worldwide Xultophy YOD young people youth β cells β-cell β-cell function

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

AstraZenecaSanofi DiabetesNovo NordiskNapp Diabetes

Silver Sponsors

Welsh Endocrinology and Diabetes Society (WEDS)AmgenAbbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership